Methylprednisolone 4mg Tablets from Japan
Oral tablets containing 4mg of methylprednisolone, a corticosteroid used for treating inflammation, allergic reactions, and autoimmune disorders. Classified under HTS 3004.32.00.40 as a mixed or unmixed product put up in measured doses for therapeutic use, specifically containing methylprednisolone.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Verify exact active ingredient concentration and ensure batch certification for methylprednisolone content to comply with FDA import requirements
• Include Certificate of Analysis (CoA) and proof of Good Manufacturing Practices (GMP) in documentation to avoid FDA holds
• Labeling must specify 'Rx only' and dosage; common pitfall is incomplete stability data leading to quarantine